|This Slide: #83 of 83|
Slide #83. Charles River Laboratories International, Inc. — Accugenix, Inc.
Charles River Laboratories International, Inc. (NYSE:CRL)
Charles River Laboratories International, Inc. announced that it has acquired Accugenix, Inc. for approximately $17 million in cash.
Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
CRL SEC Filing Email Alerts Service
Open the CRL Page at The Online Investor »
Strong Buy (3.79 out of 4)